|
Re: THIS MAY BE BIG: new monoclonalantibody-peptide conjugate crosses blood-brainbar
If this pans out, it is a major breakthrough and yet another nail in Her2positive BC's coffin. Let's see how it works out in trials. May they start soon!
Jacqueline
__________________
Diagnosed age 44, January 2004, 0.7 cm IDC & DCIS. Stage 1, grade 3, ER/PR pos. HER2 pos. clear margins, no nodes. SNB. 35 rads. On Zoladex and Armidex since Dec. 2004. Stopped Zoladex/Arimidex sept 2009 Still taking mistletoe shots (CAM therapy) Doing fine.
|
Hybrid Mode
